Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.
about
Management of hypertension in solid-organ transplantation.Immunosuppression for heart transplantation: where are we now?Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.Tacrolimus in cardiac transplantation.Impact of cyclosporine 2-h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti-thymocyte globulin induction.Relationship between endomyocardial biopsy score and cyclosporine 2-h post-dose levels (C) in heart transplant patients receiving anti-thymocyte globulin induction.
P2860
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Safety, tolerability, and effi ...... months after transplantation.
@ast
Safety, tolerability, and effi ...... months after transplantation.
@en
type
label
Safety, tolerability, and effi ...... months after transplantation.
@ast
Safety, tolerability, and effi ...... months after transplantation.
@en
prefLabel
Safety, tolerability, and effi ...... months after transplantation.
@ast
Safety, tolerability, and effi ...... months after transplantation.
@en
P2093
P1433
P1476
Safety, tolerability, and effi ...... months after transplantation.
@en
P2093
Copeland J
Costanzo MR
Frazier OH
Hauptman PJ
P356
10.1097/00007890-200101150-00012
P577
2001-01-01T00:00:00Z